TS Financial Group (TSFG)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.8M | Buy |
134,486
+6,734
| +5% | +$1.45M | 4.26% | 4 |
|
|
2026
Q1 | $27.8M | Buy |
127,752
+3,205
| +3% | +$711K | 4.22% | 5 |
|
|
2025
Q4 | $28.5M | Buy |
124,547
+1,115
| +0.9% | +$254K | 4.25% | 5 |
|
|
2025
Q3 | $28.6M | Buy |
123,432
+3,250
| +3% | +$662K | 4.54% | 4 |
|
|
2025
Q2 | $22.3M | Buy |
120,182
+3,802
| +3% | +$707K | 4.04% | 3 |
|
|
2025
Q1 | $24.4M | Buy |
116,380
+1,826
| +2% | +$355K | 4.99% | 4 |
|
|
2024
Q4 | $20.4M | Buy |
114,554
+9,866
| +9% | +$1.81M | 4.18% | 4 |
|
|
2024
Q3 | $20.7M | Sell |
104,688
-1,632
| -2% | -$305K | 4.51% | 4 |
|
|
2024
Q2 | $18.2M | Sell |
106,320
-177
| -0.2% | -$29.3K | 4.26% | 4 |
|
|
2024
Q1 | $19.4M | Sell |
106,497
-18,924
| -15% | -$3.26M | 4.89% | 4 |
|
|
2023
Q4 | $19.4M | Sell |
125,421
-2,544
| -2% | -$371K | 6.13% | 3 |
|
|
2023
Q3 | $19.1M | Buy |
127,965
+3,324
| +3% | +$488K | 6.8% | 2 |
|
|
2023
Q2 | $16.8M | Buy |
124,641
+932
| +0.8% | +$137K | 6.26% | 2 |
|
|
2023
Q1 | $19.7M | Sell |
123,709
-1,682
| -1% | -$257K | 7.31% | 1 |
|
|
2022
Q4 | $20.3M | Buy |
125,391
+4,670
| +4% | +$716K | 8.05% | 1 |
|
|
2022
Q3 | $16.2M | Buy |
120,721
+6,298
| +6% | +$904K | 7.59% | 2 |
|
|
2022
Q2 | $17.5M | Sell |
114,423
-4,882
| -4% | -$746K | 7.53% | 1 |
|
|
2022
Q1 | $19.3M | Sell |
119,305
-2,716
| -2% | -$395K | 7.01% | 2 |
|
|
2021
Q4 | $16.5M | Buy |
122,021
+11,958
| +11% | +$1.41M | 5.75% | 3 |
|
|
2021
Q3 | $11.9M | Buy |
110,063
+6,446
| +6% | +$737K | 4.63% | 3 |
|
|
2021
Q2 | $11.7M | Buy |
103,617
+3,023
| +3% | +$340K | 4.7% | 3 |
|
|
2021
Q1 | $10.9M | Buy |
100,594
+3,189
| +3% | +$341K | 5.53% | 3 |
|
|
2020
Q4 | $10.4M | Sell |
97,405
-1,538
| -2% | -$148K | 5.58% | 3 |
|
|
2020
Q3 | $8.67M | Buy |
98,943
+13,478
| +16% | +$1.27M | 5.15% | 4 |
|
|
2020
Q2 | $8.39M | Buy |
85,465
+11,946
| +16% | +$1.05M | 5.54% | 3 |
|
|
2020
Q1 | $5.6M | Sell |
73,519
-173
| -0.2% | -$14.7K | 5% | 5 |
|
|
2019
Q4 | $6.53M | Buy |
73,692
+8,731
| +13% | +$725K | 4.83% | 5 |
|
|
2019
Q3 | $4.92M | Buy |
64,961
+12,659
| +24% | +$868K | 3.77% | 7 |
|
|
2019
Q2 | $3.8M | Buy |
52,302
+13,268
| +34% | +$1.04M | 3.05% | 8 |
|
|
2019
Q1 | $3.15M | Buy |
+39,034
| New | +$3.19M | 2.68% | 9 |
|
Other funds holding ABBV
TS Financial Group (TSFG)'s ABBV Position: Q2 2026 in Review
TS Financial Group (TSFG) increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $1.45M and bringing the position to 134,486 shares worth $33.8M. The position accounts for 4.26% of the portfolio, ranked #4.
TS Financial Group (TSFG) first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TS Financial Group (TSFG) held 134,486 shares of AbbVie worth $33.8M as of Q2 2026.
- TS Financial Group (TSFG) bought 6,734 AbbVie shares in Q2 2026, an estimated $1.45M.
- AbbVie made up 4.26% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #4 holding.
- TS Financial Group (TSFG) first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
- 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.